Li Mengxing, Tang Heyong, Li Zhen, Tang Wei
College of Acupuncture and Massage (Rehabilitation Medical College), Anhui University of Chinese Medicine, Hefei 230012, China.
College of Integrated Chinese and Western Medicine (School of Life Sciences), Anhui University of Chinese Medicine, Hefei 230012, China.
Neuroscience. 2022 Dec 15;507:112-124. doi: 10.1016/j.neuroscience.2022.10.020. Epub 2022 Oct 28.
Cerebral ischemia-reperfusion injury (CI/RI) injury is a common feature of ischemic stroke which occurs when the blood supply is restored after a period of ischemia in the brain. Reduced blood-flow to the brain during CI/RI compromises neuronal cell health as a result of mitochondrial dysfunction, oxidative stress, cytokine production, inflammation and tissue damage. Reperfusion therapy during CI/RI can restore the blood flow to ischemic regions of brain which are not yet infarcted. The long-term goal of CI/RI therapy is to reduce stroke-related neuronal cell death, disability and mortality. A range of drug and interventional therapies have emerged that can alleviate CI/RI mediated oxidative stress, inflammation and apoptosis in the brain. Herein, we review recent studies on CI/RI interventions for which a mechanism of action has been described and the potential of these therapeutic modalities for future use in the clinic.
脑缺血再灌注损伤(CI/RI)是缺血性中风的一个常见特征,它发生在大脑局部缺血一段时间后血液供应恢复之时。在CI/RI期间,流向大脑的血流量减少,由于线粒体功能障碍、氧化应激、细胞因子产生、炎症和组织损伤,损害了神经元细胞的健康。CI/RI期间的再灌注治疗可以恢复尚未梗死的脑缺血区域的血流。CI/RI治疗的长期目标是减少与中风相关的神经元细胞死亡、残疾和死亡率。已经出现了一系列药物和介入治疗方法,它们可以减轻CI/RI介导的大脑氧化应激、炎症和细胞凋亡。在此,我们综述了最近关于CI/RI干预措施的研究,这些研究描述了其作用机制以及这些治疗方式在未来临床应用中的潜力。